We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Perrigo Company Plc Ireland | NYSE:PRGO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.71 | 0 | 12:00:00 |
From May 2023 to May 2024
By Will Feuer
Healthcare product and pharmaceuticals manufacturer Perrigo said the U.S. Food and Drug Administration has approved the company's oral contraceptive Opill for over-the-counter use in all ages.
Opill will be the first-ever birth control pill available over-the-counter without needing a doctor's prescription in the U.S. The oral contraceptive will be sold in stores and online at leading retailers across the U.S. early in the first quarter of 2024, Perrigo said.
Shares rose 5.8% to $35.00 in premarket trading Thursday.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
July 13, 2023 09:10 ET (13:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Perrigo Company Plc Irel... Chart |
1 Month Perrigo Company Plc Irel... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
